selective serotonin reuptake inhibitor


Also found in: Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

selective serotonin reuptake inhibitor

n.
An SSRI.
References in periodicals archive ?
Selective serotonin reuptake inhibitors (SSRIs) are the mainstay of pharmacological treatment for both depression and anxiety disorders.
Based on the result of two 8-week placebo-controlled studies including 861 patients with MDD and a 52-week open-label study including 599 patients, the company believes that the drug is associated with decreased sexual dysfunction, which is something of an Achilles' heel for selective serotonin reuptake inhibitors (SSRIs).
In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations.
SEATTLE -- Selective serotonin reuptake inhibitors are appropriate for use in adolescents: They have modest efficacy and they are safe, Dr.
These include newer medications-chiefly the selective serotonin reuptake inhibitors (SSRIs)-the tricyclics, and the monoamine oxidase inhibitors (MAOIs).
Behavioral activation was observed in 4% of the patients, significantly lower than that experienced by children and adolescents receiving other selective serotonin reuptake inhibitor agents, reported Dr.
In a case-control study of all patients admitted with gastrointestinal bleeding to three hospitals over an 18-month period, 17% of the 417 patients with bleeding were using a selective serotonin reuptake inhibitor (SSRI) at the time.
In 2005, the Food and Drug Administration rejected the short-acting selective serotonin reuptake inhibitor for use in the United States.
This concern, if unfounded, may actually be harming patients because depression, anxiety, and migraine often occur together, and many patients could benefit from taking a selective serotonin reuptake inhibitor (SSRI) and a triptan, said Dr.
It is both a Selective Serotonin Reuptake Inhibitor and a 5HT1A partial agonist that has been found to have an acceptable safety profile for this stage of development.
On average, about 61% of patients will experience at least one side effect from taking a selective serotonin reuptake inhibitor (SSRI) or a serotonin norepinephrine reuptake inhibitor (SNRI), according to the analysis.
Venlafaxine extended-release (Effexor XR) achieves remission faster than paroxetine (Paxil), a selective serotonin reuptake inhibitor with a Food and Drug Administration-approved indication for treatment of panic disorder.

Full browser ?